Our past studies have discovered novel platelet activation pathways that may be targets of therapeutic development. We have also defined an important role for a shift in platelet phenotype in vascular disease. Our studies use both in vivo animal models and validation using human platelets from isolated blood. Platelets from healthy individuals may be compared to patients with vascular diseases in the IRB approved protocol "Vascular Lab Resource" (IRB #19-1451) study which is actively recruiting patients at the Cleveland Clinic Main Campus and studies patients with vascular diseases.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults aged 18 to 65 years old
Healthy Male \& Female voluntary participants
You may not be if
Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
Individuals with hematopoetic diseases
Clareo Health | Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
